Clinical response 6 weeks after initiation of the treatment.

NIAID Data Ecosystem2026-03-07 收录

皮肤利什曼病治疗

临床疗效评估

数据链接：

https://figshare.com/articles/dataset/_Clinical_response_6_weeks_after_initiation_of_the_treatment_/730258 数据链接链接失效反馈

官方服务：

资源简介：

*ILMA = intralesioinal meglumine antimoniate. † 95% Confidence Interval.

创建时间：

2013-06-24

Overview of included RRMS phase-3 trials (n = 13).

多发性硬化症临床试验

临床疗效评估

RRF = Rate of relapse free patients after 2 years, SE = Standard error, ARR = Annualized relapse rate over 2 years, SD = Standard deviation, 2001/2005 indicates the use of the original 2001 McDonald c

Figshare2015-12-02 更新50

An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer

结直肠癌辅助化疗

临床疗效评估

This observational study evaluates the efficacy and safety of capecitabine in combination with oxaliplatin in the adjuvant setting in participants with Stage III colon cancer. Data were collected from

NIAID Data Ecosystem40

Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.

视网膜静脉阻塞

临床疗效评估

Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.

Figshare2018-09-20 更新20

COR peak week 1 improvement and COR peak week 5 improvement.

抗抑郁药物疗效

临床疗效评估

Response and remission rates after 5 weeks of treatment in 40 depressed patients (sample 2) treated with either reboxetine (n = 20) or mirtazapine (n = 20) [33]. Patients are subdivided into COR peak

NIAID Data Ecosystem50

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

临床疗效评估

医疗质量指标

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

Figshare2022-11-02 更新30